The MHRA has published its February 2026 Guide on Defective Medicinal Products. Learn what UK manufacturers and marketing authorisation holders must do regarding defect reporting, recalls, and DMRC obligations.

The new version of Swissmedic's guidance on GMP compliance verification of foreign manufacturers applies to all marketing authorization (MA) holders and their Responsible Persons (RP) in Switzerland.